We are live on ! Find out more
TMO icon

Thermo Fisher Scientific

2,365 hedge funds and large institutions have $173B invested in Thermo Fisher Scientific in 2023 Q3 according to their latest regulatory filings, with 142 funds opening new positions, 966 increasing their positions, 887 reducing their positions, and 135 closing their positions.

New
Increased
Maintained
Reduced
Closed

9% more repeat investments, than reductions

Existing positions increased: 966 | Existing positions reduced: 887

5% more first-time investments, than exits

New positions opened: 142 | Existing positions closed: 135

0.89% less ownership

Funds ownership: 89.44%88.54% (-0.89%)

1% less funds holding

Funds holding: 2,3872,365 (-22)

2% less call options, than puts

Call options by funds: $1.23B | Put options by funds: $1.25B

3% less capital invested

Capital invested by funds: $178B → $173B (-$4.73B)

1% less funds holding in top 10

Funds holding in top 10: 141139 (-2)

Holders
2,365
Holders Change
-22
Holders Change %
-0.92%
% of All Funds
37.53%
Holding in Top 10
139
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-1.42%
% of All Funds
2.21%
New
142
Increased
966
Reduced
887
Closed
135
Calls
$1.23B
Puts
$1.25B
Net Calls
-$26.6M
Net Calls Change
+$128M
Name Holding Trade Value Shares
Change
Change in
Stake
MCM
326
Mill Capital Management
North Carolina
$38.8M -$21.8K -41 -0.1%
HCM
327
Howland Capital Management
Massachusetts
$38.7M -$20.2K -38 -0%
B
328
Braidwell
Connecticut
$38.3M +$25.8M +48,449 +177%
CBUSF
329
Construction & Building Unions Superannuation Fund
Australia
$38.1M -$12.8M -24,091 -24%
C
330
Consulta
United Kingdom
$38M
Lord, Abbett & Co
331
Lord, Abbett & Co
New Jersey
$37.6M -$1.31M -2,450 -3%
GT
332
Glenmede Trust
Pennsylvania
$37.6M -$277K -519 -0.7%
NLGIA
333
Nippon Life Global Investors Americas
New York
$37.3M +$7.11M +13,340 +22%
X
334
Xponance
Pennsylvania
$37.1M -$523K -981 -1%
FT
335
Fiduciary Trust
Massachusetts
$36.7M -$569K -1,068 -1%
MIH
336
Meitav Investment House
Israel
$36.7M -$537K -1,007 -1%
NSLI
337
Nan Shan Life Insurance
Taiwan
$36.1M +$9.59M +18,000 +34%
BTCPP
338
Border to Coast Pensions Partnership
United Kingdom
$35.9M
WGAM
339
Wilkinson Global Asset Management
New York
$35.3M +$218K +410 +0.6%
ZIC
340
ZWJ Investment Counsel
Georgia
$35.1M +$89.5K +168 +0.2%
VLKIM
341
Van Lanschot Kempen Investment Management
Netherlands
$34.9M +$1.45M +2,717 +4%
IG
342
ING Group
Netherlands
$34.6M +$7.12M +13,353 +24%
EAM
343
EULAV Asset Management
Florida
$34.6M
ABC
344
Associated Banc-Corp
Wisconsin
$34.5M +$344K +646 +1%
CNB
345
Czech National Bank
Czech Republic
$34.1M +$11.6M +21,795 +48%
Los Angeles Capital Management
346
Los Angeles Capital Management
California
$33.7M -$77.4M -145,163 -69%
URS
347
Utah Retirement Systems
Utah
$33.7M +$156K +293 +0.4%
BG
348
Bellevue Group
Switzerland
$33.6M -$15.8M -29,633 -31%
DMIC
349
Dixon Mitchell Investment Counsel
British Columbia, Canada
$33.1M -$377K -708 -1%
LCAM
350
London & Capital Asset Management
United Kingdom
$33M +$34.7M +65,202 New

TMO Hedge Fund Activity: Q3 2023 in Review

2,365 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in Thermo Fisher Scientific (TMO) for Q3 2023, worth a combined $173B — down 2.7% from $178B a quarter earlier.

Buyers outnumbered sellers: 142 funds opened new TMO positions and 135 closed out — a net gain of 7 holders — while 966 added to existing stakes and 887 trimmed.

The largest buyer was DZ Bank, adding an estimated $755M. The largest seller was Arthur M. Cohen & Associates, cutting an estimated $1.66B.

  • 2,365 institutional investors held Thermo Fisher Scientific (TMO) as of Q3 2023, down from 2,387 in Q2 2023.
  • Funds reported $173B of Thermo Fisher Scientific stock for Q3 2023, down 2.7% quarter-over-quarter.
  • 142 funds opened new Thermo Fisher Scientific positions in Q3 2023 and 135 closed out, a net change of +7 holders.
  • The largest Thermo Fisher Scientific buyer in Q3 2023 was DZ Bank, an estimated $755M added.
  • The largest Thermo Fisher Scientific seller in Q3 2023 was Arthur M. Cohen & Associates, an estimated $1.66B sold.

Based on aggregated 13F filings for Q3 2023.